ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1903

Seasonal and Racial/Ethnic Variation in Achieving Target Uric Acid Levels in Gout Patients on Urate Lowering Therapy in US Veterans in Central California

Nidaa Rasheed1 and Candice Reyes2, 1UCSF Fresno, Fresno, CA, 2VACCHCS, Fresno, CA

Meeting: ACR Convergence 2025

Keywords: Environmental factors, Epidemiology, gout

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (1877–1913) Epidemiology & Public Health Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Gout is a chronic, inflammatory arthritis driven by monosodium urate (MSU) crystal deposition and elevated serum uric acid (SUA) levels, increasing the risk for cardiometabolic comorbidities and premature mortality. While gout and hyperuricemia result from complex gene-environment interactions, emerging evidence suggests that disparities in gout outcomes across racial/ethnic groups are more strongly influenced by social determinants of health than genetic factors. While prior studies have largely focused on differences in gout diagnosis and initiation of urate-lowering therapy (ULT), there is limited data on factors influencing long-term disease control. This project examined racial/ethnic and seasonal differences in maintaining target SUA (< 6 mg/dL) among patients on ULT to better understand non-genetic drivers of disease progression.

Methods: We analyzed data from the San Francisco Quality Enrichment Research Initiative, comprising 747 U.S. veterans in Central California with physician-diagnosed gout on ULT from 1999 to 2023. We excluded patients who declined to report race/ethnicity, were of mixed origin, or lacked recent SUA testing. Seasonal variation was assessed using the subset of patients with ULT and SUA measurements in 2023.

Results: Of the 386 self-identified Caucasian patients, 103 (27%) achieved target SUA, compared to 348 patients identifying as persons of color (POC) (African American, Hispanic/Latinx, Asian, American Indian, Native Hawaiian), of whom only 76 (22%) were at target SUA. African American patients were particularly affected, with just 30% achieving target levels. Overall, POC patients were significantly less likely to reach target SUA despite appropriate ULT [Odds ratio 0.61, 95% CI 0.412-0.899, P = 0.0063].Seasonal analysis revealed a notable decline in target SUA achievement in the spring and early summer, with only 38% of patients reaching goal, compared to other times of the year [Figure 2]. This seasonal effect highlights the potential impact of environmental factors like heat, dehydration, and air pollution, particularly in regions like the Central Valley, known for severe particulate and ozone pollution.

Conclusion: Our findings emphasize the need to move beyond one-size-fits-all gout management and consider the complex interplay of racial/ethnic and environmental factors that influence disease control. Providers should account for the broader social and environmental contexts, including housing location, humidity, seasonal changes, and air quality, as they may contribute to elevated SUA and increased flare risk. Addressing these factors could improve outcomes for historically marginalized groups and reduce the overall burden of gout.

Supporting image 1Figure 1. Weekly average proportion (%) of patients on ULT with uric acid labs at target (UCL = upper collection limit and LCL = lower collection limit) in the 2023 year


Disclosures: N. Rasheed: None; C. Reyes: None.

To cite this abstract in AMA style:

Rasheed N, Reyes C. Seasonal and Racial/Ethnic Variation in Achieving Target Uric Acid Levels in Gout Patients on Urate Lowering Therapy in US Veterans in Central California [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/seasonal-and-racial-ethnic-variation-in-achieving-target-uric-acid-levels-in-gout-patients-on-urate-lowering-therapy-in-us-veterans-in-central-california/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/seasonal-and-racial-ethnic-variation-in-achieving-target-uric-acid-levels-in-gout-patients-on-urate-lowering-therapy-in-us-veterans-in-central-california/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology